In the domain of pain management, SoftWave Therapy stands out for its efficacy in treating conditions characterized by chronic pain, such as fibromyalgia, neuropathic pain, and arthritis, through mechanisms that include:
Adopting SoftWave Therapy in pain management protocols offers a transformative, non-pharmacological approach that enhances patient well-being and functionality.
For sports medicine, SoftWave Therapy facilitates the treatment and recovery of acute and chronic sports-related injuries, such as High Ankle Sprains and Stress Fractures, by:
SoftWave Therapy’s comprehensive benefits in sports medicine underscore its utility in not only facilitating athlete recovery but also in preventing injuries, thereby supporting athletes in maintaining peak performance levels.
Urological applications of SoftWave Therapy include the management of erectile dysfunction and chronic pelvic pain syndrome, where it offers:
This non-invasive therapy provides a promising alternative to conventional treatments, aiming to enhance patient outcomes in urological care.
In podiatric medicine, SoftWave Therapy has demonstrated substantial efficacy in the management of complex conditions such as plantar fasciitis and Morton’s Neuroma. The therapeutic mechanism involves:
The FDA’s clearance of SoftWave Therapy for diabetic foot ulcers underscores its safety and effectiveness, offering a powerful tool for podiatric conditions that accelerates patient recovery.
Chiropractors find SoftWave Therapy beneficial for treating peripheral conditions such as Carpal Tunnel Syndrome and epicondylitis (Golfer’s and Tennis Elbow). The therapy contributes to:
Incorporating this therapy into chiropractic care extends the range of treatable conditions, offering a holistic approach that aligns with the principles of chiropractic medicine.
Elevate your practice to the forefront of medical innovation and achieve superior patient results with maximum ROI
SoftWave Therapy is not only a preferred choice among private healthcare providers but also a recognized option for government medical facilities, having secured a General Services Administration (GSA) contract
SoftWave’s patented unfocused shockwave therapy devices are FDA-cleared and effective at treating a variety of soft tissue injuries and conditions.
Low-Intensity Shockwave Therapy (Li-ESWT) is an evidence-based approach to improving patient outcomes.
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
Alison N. Schroeder, MD; Adam S. Tonforde, MD
